A detailed history of Life Plan Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Life Plan Investment Advisors, Inc. holds 304 shares of LLY stock, worth $225,674. This represents 0.17% of its overall portfolio holdings.

Number of Shares
304
Previous 304 -0.0%
Holding current value
$225,674
Previous $275 Million 2.13%
% of portfolio
0.17%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jan 21, 2025

BUY
$724.87 - $909.04 $4,349 - $5,454
6 Added 2.01%
304 $275 Million
Q1 2024

Jan 21, 2025

BUY
$592.2 - $792.28 $176,475 - $236,099
298 New
298 $232 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $705B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Life Plan Investment Advisors, Inc. Portfolio

Follow Life Plan Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Plan Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Life Plan Investment Advisors, Inc. with notifications on news.